Dosidal · Switzerland

Noxafil, Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65172 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65172
atc: J02AC04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2015-12-16
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J02AC04
authorisation_number: 65172
form: LSPA
holder: MSD Merck Sharp & Dohme AG
holder_partner_nr: 1003060
it_number: 08.06.0.
name: Noxafil, Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
hyg9msW3uy_EMaCvNYb0bvFzvQBGyFHfcWEyCCtLuPHpMsIvvlQA5OepxN2c_6s7ZV4MGt2vGr3iJHB1mFsUuQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal